FMI Releases New Report on the Drug Designing Tools Market 2017-2027

Drug designing tools are software and databases that are used at an early stage of modern drug discovery process. The use of computers and computational tools have permeated all aspects of drug-discovery and have formed essential part of structure-based drug design. Drug discovery and development is tremendous lengthy process involving multiple disciplines such as chemistry, biology, biophysics, structural biology and computational science. Typical drug discovery starts with target identification, lead discovery & optimization, pre-clinical in vitro and in vivostudies involving approximately 12 to 14 years and costs up to US$ 1.2 to 1.4 Bn. However, in silico screening of chemical database has now become the important tool to reduce the time, cost and chances of failure of lead at later stage of development. Computer aided drug designing or in silico drug designing has gained significant momentum in past 3 decades. There are different techniques used in in silico drug designing and including visualization, molecular dynamics simulation, homology, energy minimization tools, molecular docking etc. drug discovery tools can be used in all stages of drug development including discovery pre-clinical and clinical stage. Today all pharmaceutical and biotechnology companies take the advent of drug designing tools to cut down the time and resources required in drug development process and modern drug discovery is almost impossible without the use of computational tools. Thus market for drug designing tools is ever growing with rapid technological advancements developments.

Drug Designing Tools Market: Drivers and Restraints

The primary factor driving the growth of global drug designing tools market is increasing pace of research and development in all verticals of pharmaceutical, biotechnology and life science industries. Moreover, immediate need of medicines to treat chronic diseases such as cancer, diabetes, etc., increasing complexity of drug discovery due to huge amount of biological data, need for simplified ways to handle big data generated during drug discovery process, growing stringency in regulations for animal handling, etc. are some others factors fueling the demand for drug designing tools. The only factors hampering the growth of global drug designing tools market are high cost of such tools and lack of skilled professionals to operate the tools. \

Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-3806

Drug Designing Tools Market: Segmentation

Tentatively, the global drug designing tools market has been segmented on the basis of product type,, end user, and geography.

Based on product type, the global drug designing tools market is divided into following:

• Databases

• Virtual Screening Tools

• Structure Designing/Building Tools

• Predictive Models

• Model Building Tools

• Others

Based on application, the global drug designing tools market is segmented as below:

• Chemical Screening

• Molecular Modeling/Homology Modeling

• Target Prediction

• Binding Site Prediction

• Docking

• Molecular Dynamic Simulations

• Energy Minimization

• Others

Based on end user, the global drug designing tools market is segmented as below:

• Pharmaceutical Companies

• Biotechnology Companies

• Academic and Research Institutes

• Contract Research Organizations

• Others

Drug Designing Tools Market: Overview

The global market for drug designing tools is highly consolidated and very few number of big players constitute 70% the entire market. Development of drug designing tools also require huge investment of time and is thus limited to IT giants.

Drug Designing Tools Market: Regional Outlook

Geographically, drug designing tools market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America is expected to be the leader in global drug designing tools market owing to increasing pace and capability of research and development. Europe is expected to be the second largest market for drug designing tools. The market in Asia Pacific and Japan is expected to grow at significant CAGR due to increasing academic research activities and growing number of academic institutes. Market in MEA and Eastern Europe is expected to witness sluggish growth over the forecast period.

Drug Designing Tools Market: Key Players

Some of the major players in the drug designing tools market are Schrödinger LLC, Gaussian Inc., Accelrys, BioSolveIT GmbH, COSMOlogic GmbH & Co., Certara, L.P, PerkinElmer Inc., Simulations Plus, ChemAxon, OpenEye Scientific Software Inc., in silico toxicology gmbh among others.

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. Fmi is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India